Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Research and Practice in Thrombosis and Haemostasis|March 13, 2023
Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint statusJudit Rejtő, Daniel Kraemmer, Ella Grilz, et al.
Annals of Hematology|December 27, 2016
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown causeJohanna Gebhart, Sylvia Kepa, Stefanie Hofer, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Blood Advances|June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand diseaseCihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Research and Practice in Thrombosis and Haemostasis|March 13, 2023
Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint statusJudit Rejtő, Daniel Kraemmer, Ella Grilz, et al.
Annals of Hematology|December 27, 2016
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown causeJohanna Gebhart, Sylvia Kepa, Stefanie Hofer, et al.
Hepatology International|October 1, 2020
Thromboelastometry in patients with advanced chronic liver disease stratified by severity of portal hypertensionPierre Raeven, Joanna Baron-Stefaniak, Benedikt Simbrunner, et al.
Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.
Thrombosis and Haemostasis|May 21, 2021
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and AscitesJohannes Thaler, Ton Lisman, Peter Quehenberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.
Blood Advances|June 30, 2022
The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand diseaseCihan Ay, Ingrid Pabinger, Katarina D Kovacevic, et al.
Journal of Thrombosis and Haemostasis : JTH|February 20, 2020
Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non-severe haemophilia AJudit Rejtő, Oliver Königsbrügge, Ella Grilz, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2024
Fibrinolysis is impaired in patients with primary immune thrombocytopeniaTheresa Schramm, Jasmin Rast, Dino Mehic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Pageof 14